Viewing Study NCT06656234


Ignite Creation Date: 2025-12-25 @ 2:24 AM
Ignite Modification Date: 2025-12-27 @ 11:20 PM
Study NCT ID: NCT06656234
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-10-24
First Post: 2024-10-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Effectiveness and Safety of Glofitamab in Real-World Clinical Practice Among Chinese Adult Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Prospective, Observational, Multicenter Study
Sponsor: Ruijin Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module